Stryker said net sales for Q1 rose to $5.9 billion, up 11.9%, or 12.8% in constant currency. Organic growth was 10.1%, of which 9.4% came from higher unit volume and 0.7% from higher prices.

1. 01

   Stryker said net sales for Q1 rose to $5.9 billion, up 11.9%, or 12.8% in constant currency. Organic growth was 10.1%, of which 9.4% came from higher unit volume and 0.7% from higher prices.

2. 02

   The company said net earnings for Q1 fell 17.0% to $654 million, and diluted earnings per share fell 17.6% to $1.69. Adjusted diluted earnings per share rose 13.6% to $2.84, and the adjusted operating income margin was 22.9%.

3. 03

   The company said that for the 3-month period in Q1, operating cash flow was $250 million, and it spent $4,749 million on acquisitions, net of cash acquired. Over the same period, net debt borrowings were $2,979 million, and dividend payments were $320 million.

4. 04

   The company said it is raising its full-year organic net sales growth guidance range to 8.5% to 9.5%. Its adjusted diluted earnings per share guidance is $13.20 to $13.45. The company said the updated guidance offsets a tariff impact of approximately $200 million.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.